Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection. - Suppr | 超能文献

Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection.

作者信息

Scartozzi R, Chao J R, Walsh A C, Eliott D

出版信息

Eye (Lond). 2009 May;23(5):1229. doi: 10.1038/eye.2008.162. Epub 2008 Jun 6.

DOI:10.1038/eye.2008.162

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection.

Eye (Lond). 2009 May;23(5):1229. doi: 10.1038/eye.2008.162. Epub 2008 Jun 6.

2

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗持续性弥漫性糖尿病性黄斑水肿。

Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.

3

[Avastin a treatment of diabetic macular edema].

Oftalmologia. 2011;55(1):63-7.

4

Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗糖尿病黄斑水肿的初步研究。

Eye (Lond). 2009 Mar;23(3):616-20. doi: 10.1038/eye.2008.40. Epub 2008 Apr 25.

5

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.玻璃体内注射贝伐单抗（阿瓦斯汀）对慢性弥漫性糖尿病性黄斑水肿患者的长期影响。

Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.

6

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).玻璃体内注射曲安奈德与贝伐单抗治疗难治性糖尿病性黄斑水肿（IBEME研究）

Br J Ophthalmol. 2008 Jan;92(1):76-80. doi: 10.1136/bjo.2007.129122. Epub 2007 Oct 26.

7

The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.单侧玻璃体内注射贝伐单抗（阿瓦斯汀）治疗双侧弥漫性糖尿病性黄斑水肿的疗效：一项初步研究。

Retina. 2009 Jan;29(1):20-6. doi: 10.1097/IAE.0b013e318186c64e.

8

Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.玻璃体内注射贝伐单抗联合/不联合曲安奈德单次注射治疗糖尿病黄斑水肿。

Chin Med J (Engl). 2011 Feb;124(3):352-8.

9

Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.玻璃体内注射贝伐单抗或曲安奈德治疗糖尿病性黄斑弥漫性水肿。

Acta Ophthalmol. 2010 Mar;88(2):e36-7. doi: 10.1111/j.1755-3768.2008.01443.x.

10

Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.单次玻璃体内注射贝伐单抗与曲安奈德作为弥漫性糖尿病性黄斑水肿主要治疗方法的比较

Acta Ophthalmol. 2012 Mar;90(2):e160-1. doi: 10.1111/j.1755-3768.2010.02098.x. Epub 2011 Apr 6.

引用本文的文献

1

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs.玻璃体内注射贝伐单抗和雷珠单抗对侧眼黄斑水肿的影响：两种抗血管内皮生长因子药物的对比研究

Oman J Ophthalmol. 2016 Jan-Apr;9(1):44-8. doi: 10.4103/0974-620X.176100.

2

Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.糖尿病性黄斑水肿患者单眼玻璃体内注射贝伐单抗后的对侧眼效应

Eye (Lond). 2014 Jun;28(6):646-53. doi: 10.1038/eye.2014.94. Epub 2014 May 23.

3

Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?贝伐单抗用于治疗年龄相关性黄斑变性的超说明书用药：证据是什么？

Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002.